出处
《医学综述》
2004年第8期456-458,共3页
Medical Recapitulate
基金
国家自然科学基金项目 (39970 867)
参考文献17
-
1Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis[J]. Cell, 1996,86(3):353-364.
-
2Mouhon KS. Plaque anglogenesis and atheroslerosis[J]. Curt Atheroscler Rep,2001,3(3) :225-233.
-
3Boyle J, Wilson B, Bicknell R, et al. Expression of angiogenic factor thymidine phosphorylase and angiogenesis in human atherosclerosis[ J].J Pathol,2000,192(2) :234-242.
-
4Moulton KS, Heller E, Konerding MA, et al. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E deficient mice [ J]. Circulation, 1999, 99(13) : 1726-1732.
-
5Bornstein P. Thrombospondins: structure and regulation of expression[J]. FASEB J, 1992,6(14) :3290-3299.
-
6Tan K, Duquette M, Liu JH, et al. Crystal structure of the TSP-1 type 1 repeats: a novel layered fold and its biological implication [ J ]. J Cell Biol, 2002,159 (2) : 373-378.
-
7Silverstein RL, Nachman RL. Angiogenesis and atherosclerosis: Themandate broadens[ J]. Circulation, 1999,100(8) :783-788.
-
8Dawson DW, Pearce SF, Zhong R, et al. CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells [ J]. J Cell Biol, 1997,138(3) :707-717.
-
9Febbraio M, Hajjar DP, Silverstein RL, CD36 : a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism[ J ]. J Clin Invest, 2001,108(6) : 785-791.
-
10Volpert O. Modulation of endothelial cell survival by an inhibitor of angiogenesis thrombospondin-1 : a dynamic balance [ J ]. Cancer MetastasisRev, 2000,19(1-2) :87-92.
同被引文献24
-
1邹贵勉,张璟,周飞舟.TGF-β1诱导人肾小管上皮细胞血小板反应蛋白1的表达[J].中国血液净化,2005,4(7):384-386. 被引量:5
-
2赵雷,王莉,姜叙诚,郑林,张帆,赵涵芳,许伟榕.hVEGF基因工程生物膜覆盖大鼠全层皮肤缺损创面的模型建立[J].实验动物与比较医学,2006,26(1):19-22. 被引量:5
-
3赵雷,王莉,姜叙诚,郑林,张帆,赵涵芳,许伟榕.hVEGF基因工程生物膜对全层皮肤缺损创面愈合的影响[J].上海交通大学学报(医学版),2006,26(9):1015-1018. 被引量:6
-
4Gitay-Goren H, Soker S, Vlodavsky I, et al. The binding of vascular endothelial growth factor to its receptors is depend on cell surface- associated heparin-like molecules[J]. J Bid Chem, 1992, 267 (9) : 6093 - 6098.
-
5Fong GH, Rossant J, Gertsenstein M, et al. Role of the fit-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium [ J]. Nature, 1995,376(6535) :66 - 70.
-
6Lawler J. Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth [ J ]. J Cell Mol Med, 2002,6 ( 1 ) :1 - 12.
-
7Koul D, Shen R, Giryali A, et al. MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor mediated angiogenesis prostate cancer[ J]. Oncol, 2002, 21(3) :469 -475.
-
8Schroeder JW Jr, Rastatter JC, Walner DL. Effect of vascular endothelial growth factor on laryngeal wound healing in rabbits [ J ]. Otolaryngol Head Neck Surg, 2007, 137 (3) :465 - 470.
-
9Bussolati B, Dunk C, Grohman M, et al. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor- mediated angiogenesis via nitric oxide[ J]. Am J Pathol, 2001,159 (3) :993 - 1008.
-
10Tabruyn SP, Griffioen AW. Molecular pathways of angiogenesis inhibition [ J ]. Biochem Biophys Res Commun, 2007,355 ( 1 ) : 1 - 5.
引证文献2
-
1罗天永,李媛媛,吴君,周晓倩.血小板反应蛋白-1在大鼠肝纤维化中表达的意义[J].贵州医药,2007,31(10):873-876. 被引量:3
-
2赵雷,王莉,姜叙诚,郑林,张帆,赵涵芳,许伟榕.hVEGF基因工程生物膜对全层皮肤缺损创面中flt-1和TSP-1表达的影响[J].上海交通大学学报(医学版),2009,29(1):47-50.
二级引证文献3
-
1黄卫国,程爱兰,周建国,苏琦.蛋白组学方法筛选HBV肝纤维化临床血清生物学标记物[J].临床和实验医学杂志,2010,9(13):1007-1009. 被引量:4
-
2庞青,田峰,刘昌.血小板与肝纤维化的关系[J].实用肝脏病杂志,2011,14(4):315-317. 被引量:13
-
3张珍,姜娜,邵兴华,井冉,车霞静,庞慧华,牟姗,倪兆慧.血小板反应蛋白1通过活化转化生长因子β1促进人间皮细胞间皮间叶转化[J].上海医学,2015,38(7):590-595. 被引量:5
-
1朱莉,江波,黄铮.静脉输入中药注射剂发生不溶性微粒的原因分析及对策[J].中华现代护理杂志,2011,17(11):1361-1363. 被引量:8
-
2范柏林,刘增路,唐玫,周黎敏,毛振民.血管生成抑制剂研究进展[J].中国现代应用药学,2009,26(1):22-25. 被引量:4
-
3李云峰,叶盛威,胡明芬.环氧化酶-2抑制剂影响肿瘤血管生成的机制[J].云南医药,2002,23(6):492-494.
-
4高晶,袁淑杰,姜媛媛,李郑武.贝伐单抗在抗肿瘤临床上的应用[J].科学中国人,2016(3X).
-
5张建初,熊先智,辛建保,刘纬,杨卫兵,白明.P53蛋白调节血管紧张素Ⅱ诱导的内皮细胞凋亡[J].华中科技大学学报(医学版),2002,31(3):280-283. 被引量:7
-
6张癸荣,鲁燕侠,吴芳.局部外用抗感染药物治疗烧伤[J].中华医院感染学杂志,2011,21(14):3031-3031. 被引量:5
-
7黄河清,黄骏.克糖症治疗2型糖尿病的临床观察[J].现代中西医结合杂志,2002,11(3):194-195.
-
8抗肿瘤、抗癌药物[J].国外科技资料目录(医药卫生),1999(11):201-201.
-
9金伟款.新血管生成抑制剂kallistatin[J].国外药讯,2003(4):21-21.
-
10孙菊云.Endostatin抑制内皮细胞和抗肿瘤的研究进展[J].医学综述,2002,8(11):632-633.